Weave Communications, Inc.
NYSE:WEAVSoftware - Application
-$0.09 today
- Market cap
- $595.33M
- Beta
- 1.69
- P/E (TTM)
- -16.4
- EPS (TTM)
- -$0.32
Volume 1.24M
Average 1.30M
WEAV Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Weave Communications, Inc.NYSE: WEAV
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures growth accelerates
Q1 FY2026 capital expenditures of $521K (cash outflow) rose 17.3% year over year, ahead of the -17.8% change in trailing-twelve-month capital expenditures. Sequentially, it fell 53.6% from the prior quarter. Over 3 fiscal years it compounded at -8.6% a year.
Context
- Capital expenditures amounted to 1.0% of revenue in FY2025, unchanged from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +17.3% holds above the trailing-twelve-month pace of -17.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (2.39M) USD
- Year-over-year change
- -9.3%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.39M) | -9.3% |
| FY2024 | 2024-12-31 | (2.19M) | +40.8% |
| FY2023 | 2023-12-31 | (3.69M) | -18.0% |
| FY2022 | 2022-12-31 | (3.13M) | +68.1% |
| FY2021 | 2021-12-31 | (9.81M) | — |
Capital Expenditures vs competitors
How WEAV compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -17.8% is the 9th highest of 10, against a peer median of +19.7%.
- Capital expenditures amounts to 1.0% of revenue for WEAV, versus a peer median of 1.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $13.38M USD | +126.0% | -6.3% | 4.4% | |
| LTM Mar 2026 | $12.67M USD | +41.9% | -10.6% | 1.4% | |
| LTM Mar 2026 | $9.02M USD | +3.8% | -33.5% | 6.0% | |
| LTM Apr 2026 | $8.87M USD | -9.9% | +7.6% | 2.8% | |
| LTM Mar 2026 | $3.85M USD | +19.7% | +31.1% | 0.8% | |
AMBQAmbiq Micro, Inc. | LTM Mar 2026 | $3.5M USD | +34.9% | — | 4.3% |
| LTM Mar 2026 | $2.47M USD | -17.8% | -8.6% | 1.0% | |
| LTM Mar 2026 | $1.5M USD | +382.3% | +9.7% | 1.9% | |
| LTM Mar 2026 | $243K USD | -85.3% | +16.9% | 0.6% | |
| LTM Mar 2026 | $22K USD | -15.4% | -39.4% | 0.0% | |
NBPNovaBridge Biosciences | LTM Sep 2025 | CN¥41 CNY | — | -94.7% | — |
| Peer median (excluding WEAV) | — | +19.7% | -6.3% | 1.9% | |
Competitors are the stored peer set for WEAV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (51.69M) | (49.74M) | (31.03M) | (28.35M) | (28.05M) |
| Depreciation & Amortization | 12.14M | 16.65M | 15.83M | 15.47M | 15.63M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 14.09M | 18.75M | 22.82M | 32.22M | 32.13M |
| Change in Working Capital | (4.68M) | (9.87M) | (8.09M) | (18.35M) | (18.09M) |
| Accounts Receivables | (870K) | (966K) | (1.38M) | 1.87M | (1.61M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 583K | (330K) | 1.32M | 3.12M | (1.09M) |
| Other Working Capital | (4.39M) | (8.57M) | (8.03M) | (23.33M) | (15.39M) |
| Other Non-Cash Items | 9.77M | 11.44M | 10.68M | 13.15M | 15.92M |
| Operating Cash Flow | (20.37M) | (12.77M) | 10.22M | 14.15M | 17.54M |
| Capital Expenditures | (9.81M) | (3.13M) | (3.69M) | (2.19M) | (2.39M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | (23.86M) |
| Purchases of Investments | 0 | (50.92M) | (66.2M) | (53.77M) | (36.77M) |
| Sales of Investments | 0 | 0 | 62.15M | 66.44M | 58.46M |
| Other Investing Activities | (2.43M) | (1.22M) | (2M) | (1.6M) | (2.29M) |
| Investing Cash Flow | (9.81M) | (54.03M) | (7.74M) | 8.88M | (6.85M) |
| Debt Repayment | (1.86M) | (8.71M) | (17.53M) | (7.06M) | (7.17M) |
| Common Stock Issued | 111.6M | 0 | 0 | 3.72M | 2.7M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 740K | 1.5M | 3.81M | (18.86M) | (2.86M) |
| Financing Cash Flow | 110.48M | (7.21M) | (13.72M) | (22.19M) | (7.33M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 80.3M | (74M) | (11.24M) | 840K | 3.36M |
| Free Cash Flow | (30.18M) | (15.89M) | 6.53M | 11.96M | 15.15M |
Weave Communications, Inc.
NYSE:WEAV
Intrinsic Alpha fair value
Locked
Current Price
$7.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.